Pharmaceutical giant AstraZeneca will offer U.S. patients discounted prices for some prescription drugs, President Trump announced Friday, the second major drug company to strike a deal with the Trump administration in recent weeks.

Under the deal, AstraZeneca will offer its drugs to Medicaid patients at "most-favored-nation" prices, meaning the U.K.-based drugmaker will charge no more than the lowest rate offered in other high-income countries, Centers for Medicare and Medicaid Services Administrator Mehmet Oz said in a Friday afternoon Oval Office event. AstraZeneca also promised to offer new prescription drugs at most-favored-nation rates, Oz said.

AstraZeneca will also list "all primary care medications" on a government website called TrumpRx, and it will offer discounts for some dru

See Full Page